What is the cause of Creutzfeldt-Jakob disease (CJD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Creutzfeldt-Jakob Disease (CJD)

Creutzfeldt-Jakob disease is caused by abnormal prions, which are infectious proteins that misfold and accumulate in the brain, leading to progressive neurodegeneration and ultimately death. 1, 2

Types and Etiologies of CJD

CJD can be acquired through several distinct mechanisms:

1. Sporadic CJD (sCJD)

  • Most common form (approximately 90% of cases) with an incidence of 1.5-2.0 per million person-years 1
  • Believed to occur spontaneously through posttranslational conversion of normal prion protein (PrP^c) into pathological variant (PrP^Sc) 3
  • No identifiable source of infection or genetic mutation
  • Associated with polymorphism at codon 129 of the prion protein gene (PRNP) and molecular mass of PrP^Sc (glycotype 1 and 2) 1

2. Familial/Genetic CJD

  • Inherited in an autosomal dominant pattern
  • Caused by specific mutations in the PRNP gene
  • Notable mutations include:
    • D178N mutation (as reported in the first kindred from South-East Asia) 4
    • Codon 200 mutations 3
  • Homozygosity for these mutations increases disease manifestation risk 3

3. Acquired CJD

  • Iatrogenic CJD: Transmitted through medical procedures including:

    • Corneal transplants from infected donors
    • Human growth hormone and gonadotropin from infected pituitary glands
    • Inadequately sterilized neurosurgical instruments (depth electrodes)
    • Contaminated dura mater grafts used in neurosurgical procedures 3
  • Variant CJD (vCJD):

    • Caused by the same prion protein that causes Bovine Spongiform Encephalopathy (BSE) in cattle 1
    • Differs from sporadic CJD in that prion proteins are found not only in brain, spinal cord, and posterior eye, but also in lymph nodes, appendix, and tonsils 1
  • Kuru:

    • Historically acquired through ritual cannibalism (no longer practiced) 3

Pathophysiology

  • CJD belongs to a group of disorders called Transmissible Spongiform Encephalopathies (TSEs) 1
  • The disease process involves:
    1. Conversion of normal cellular prion protein (PrP^c) to pathological scrapie prion protein (PrP^Sc)
    2. Accumulation of misfolded proteins in neurons
    3. Progressive neurodegeneration without typical inflammatory response 5
  • Prion proteins become detectable in tissues during later incubation periods and reach higher concentrations once the disease manifests 1

Transmission Risks

  • Prions are highly resistant to standard sterilization procedures
  • Microscopic tissue traces on surgical instruments can remain infectious even after washing and autoclaving 1
  • Successive washing reduces concentration of infectious material (after approximately 10 decontamination cycles, infectivity becomes negligible) 1
  • Tissues with high infectivity include brain, spinal cord, and posterior eye (for sporadic CJD) 1
  • Medium infectivity tissues include lymphoid tissue, including adenoid and tonsil (particularly for vCJD) 1
  • Unproven transmission routes include blood transfusion, surgical sutures, tonometers, and consumption of certain animal organs 3

Diagnostic Considerations

  • Definitive diagnosis requires neuropathological confirmation 1
  • RT-QuIC testing of CSF has high specificity (near 100%) and sensitivity (73-97%) 2
  • MRI with DWI and FLAIR sequences showing cortical ribboning and basal ganglia/thalamic hyperintensities 2
  • CSF biomarkers include 14-3-3 protein and elevated total Tau protein 1, 2
  • EEG may show characteristic periodic sharp-wave complexes (PSWCs) 2

CJD is universally fatal, with median survival of only 5 months after symptom onset, with most patients dying within one year of diagnosis 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Creutzfeldt-Jakob Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How is Creutzfeldt-Jakob disease acquired?

Neuroepidemiology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.